PD-0325901

PD-0325901 · Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PD-0325901, covering 2014-11-26 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC [Phase 1, Phase 2]